The molecular basis of salivary gland involvement in graft-vs.-host disease

Journal of Dental Research

Volumn 83, Issue 2, 2004, Pages 98-103

  Nagler, R M ^a,b   Nagler, A ^c  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Graft vs. host disease; Saliva; Salivary gland; Sialochemistry; Sialometry

Indexed keywords

AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CHEMISTRY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; MOLECULAR BIOLOGY; REVIEW; SALIVA; SALIVARY GLAND DISEASE; SJOEGREN SYNDROME;

AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MOLECULAR BIOLOGY; SALIVA; SALIVARY GLAND DISEASES; SJOGREN'S SYNDROME;

EID: 4143050099     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910408300203     Document Type: Short Survey

References (46)

1. Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, et al. (1998). Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. New Engl J Med 339:1186-1193.
2. Brattström C, Tollemar J, Ringden O, Bergström K, Tyden G (1991). Isoamylase levels in bone marrow transplant patients are affected by total body irradiation and not by graft-versus-host disease. Transpl Int 4:96-98.
3. Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG (2001). Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 98:1594-1600.
4. Chaushu S, Chaushu G, Garfunkel AA, Slavin S, Or R, Yefenof E (1994a). Salivary immunoglobulins in recipients of bone marrow grafts. I. A longitudinal follow-up. Bone Marrow Transplant 14:871-876.
5. Chaushu S, Chaushu G, Garfunkel A, Slavin S, Or R, Yefenof E (1994b). Salivary immunoglobulins in recipients of bone marrow grafts. II. Transient secretion of donor-derived salivary IgA following major transplantation of T cell-depleted bone marrow. Bone Marrow Transplant 14:925-928.
6. Chisholm DM, Mason DK (1968). Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 21:656-660.
7. Deville de Périère D, Aranciba S (1988-89). Salivary hormones: a new aspect of oral physiology. J Physiol (Paris) 83:273-280.
8. Fox PC, Van der Ven P, Sonies BC, Weiffenbach JM, Baum BJ (1985). Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc 110:519-525.
9. Gaziev D, Galimberti M, Lucarelli G, Polchi P (2000). Chronic graft-versus-host disease: is there an alternative to the conventional treatment? [review]. Bone Marrow Transplant 25:689-696.
10. Goral J, Mathews HL, Nadler SG, Clancy J (2000). Reduced levels of Hsp 70 result in a therapeutic effect of 15-deoxyspergualin on acute graft-versus-host disease in (DA x LEW) F1 rats. Immunobiology 202:254-266.
11. Higaki Y, Yamada O, Okamura T, Mizoguchi H, Kawashima M (2001). Granzyme-B-containing lymphocyte involvement in epidermal injury in graft-versus-host disease. Dermatology 202:94-98.
12. Hiroki A, Nakamura S, Shinohara M, Oka M (1994). Significance of oral examination in chronic graft-versus-host disease. J Oral Pathol Med 23:209-215.
13. Hiroki A, Nakamura S, Shinohara M, Gondo H, Ohyama Y, Hayashi S, et al. (1996). A comparison of glandular involvement between chronic graft-versus-host disease and Sjögren's syndrome. Int J Maxillofac Surg 25:298-307.
14. Han Y, Gotsman I, Pines M, Beinart R, Zeria M, Ohana M, et al. (2000). Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model. Blood 95:3613-3619.
15. Itoh S, Matsuzaki Y, Kimura T, Unno R, Ikegami T, Shoda J, et al. (2000). Suppression of hepatic lesions in a murine graft-versus-host reaction by antibodies against adhesion molecules. J Hepatol 32:587-595.
16. Itoi H, Fujimori Y, Tsutsui H, Matsui K, Futatsugi S, Okamura H, et al. (2001). Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease. Blood 98:235-237.
17. Izutsu KT, Sullivan KM, Schubert MM, Truelove EL, Shulman HM, Sale GE, et al. (1983a). Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease. Transplantation 35:441-446.
18. Izutsu KT, Schubert MM, Truelove EL, Shulman HM, Sale GE, Morton TH, et al. (1983b). The predictive value of elevated labial saliva sodium concentration: its relation to labial gland pathology in bone marrow transplant recipients. Hum Pathol 14:29-35.
19. Izutsu KT, Menard TW, Schubert MM, Ensign WY, Sullivan K, Truelove EL, et al. (1985). Graft versus host disease-related secretory immunoglobulin A deficiency in bone marrow transplant recipients. Findings in labial saliva. Lab Investig 52:292-297.
20. Izutsu KT, Schubert MM, Truelove EL, Johnson DE (1987). Use of human minor salivary glands in basic and applied secretion research. J Dent Res 66:654-659.
21. Janin-Mercier A, Devergie A, Van Cauwenberge D, Saurat JH, Bourges M, Lapiere CM, et al. (1984). Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man. Am J Pathol 115:296-306.
22. Kichian K, Nestel FP, Kim D, Ponka P, Lapp WS (1996). IL-20 p40 messenger RNA expression in target organs during acute graft-versus-host disease. Possible involvement of IFN-gamma. J Immunol 157:2851-2856.
23. Marmary Y, Okon E, Katz J, Shiloni E (1994). Effect of interleukin-2 on salivary gland morphology and function in mice. Lymphokine Cytokine Res 13:197-201.
24. Marti U, Burwen SJ, Jones AL (1989). Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology 9:126-138.
25. Maruya E, Saji H, Seki S, Fujii Y, Kato K, Kai S, et al. (1998). Evidence that CD31, CD49b and CD62L are immunodominant minor histocompatibility agents in HLA identical sibling bone marrow transplants. Blood 92:2169-2176.
26. Matsuda Y, Hara J, Osugi Y, Tokimasa S, Fujisaka H, Takai K, et al. (2001). Serum levels of soluble adhesion molecules in stem cell transplantation-related complications. Bone Marrow Transplant 27:977-982.
27. Nagler RM, Nagler A (1999). Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study. Bone Marrow Transplant 23:1007-1011.
28. Nagler RM, Nagler A (2001). The effect of pilocarpine on saliva constituents in patients with chronic graft-versus-host disease. Arch Oral Biol 46:689-695.
29. Nagler RM, Nagler A (2003). Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease - a prolonged study. Cancer Invest 11:34-40.
30. Nagler R, Marmary Y, Krausz Y, Chisin R, Markitziu A, Nagler A (1996a). Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 17:219-224.
31. Nagler RM, Laufer D, Nagler A (1996b). Parotid gland dysfunction in an animal model of chronic graft-versus-host disease. Arch Otolaryngol Head Neck Surg 122:1057-1060.
32. Nagler A, Nagler RM, Ackerstein A, Levy S, Marmary Y (1997). Major salivary gland dysfunction in patients with hematological malignancies receiving interleukin-2 based immunotherapy post-autologous blood stem cell transplantation (ABSCT). Bone Marrow Transplant 20:575-580.
33. Nagler RM, Laufer D, Nagler A (1998). Parotid gland dysfunction in a murine model of acute graft versus host disease [aGVHD]. Head Neck 20:58-62.
34. Nagler A, Pines M, Abadi U, Pappo O, Zeria M, Rabbani E, et al. (2000). Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice. Hepatology 31:641-648.
35. Nakhleh RE, Miller W, Snover DC (1989). Significance of mucosal vs salivary gland changes in lip biopsies in the diagnosis of chronic graft-vs-host disease. Arch Pathol Lab Med 113:932-934.
36. Norhagen G, Engström PE, Björkstrand B, Hammarström L, Smith CI, Ringden O (1994). Salivary and serum immunoglobulins in recipients of transplanted allogeneic and autologous bone marrow. Bone Marrow Transplant 14:229-234.
37. Panoskaltsis-Mortari A, Taylor PA, Rubin JS, Uren A, Welniak LA, Murphy WJ, et al. (2000). Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury. Blood 96:4350-4356.
38. Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, et al. (2000). Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 342:1846-1854.
39. Schmitz N, Beksac M, Hasenclever D, Bacigalupo A, Ruutu T, Nagler A, et al. (2002). Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 100:761-767.
40. Serody JS, Burkett SE, Panoskaltsis-Mortari A, Ng-Cashin J, McMahon E, Matsushima GK, et al. (2000). T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung and spleen during graft-versus-host disease. Blood 96:2973-2980.
41. Shimoni A, Nagler A (2001). Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulation. Leukemia 15:1967-1975.
42. Shulman HM, Sale GE, Lerner KG, Barker EA, Weiden PL, Sullivan K, et al. (1978). Chronic cutaneous graft-versus-host disease in man. Am J Pathol 91:545-570.
43. Singhal S, Mehta J, Rattenbury H, Treleaven J, Powles R (1995). Oral pilocarpine hydrochloride for the treatment of refractory xerostomia associated with chronic graft-versus-host disease. Blood 85:1147-1148.
44. Slavin S, Nagler A (1991). New developments in bone marrow transplantation. Curr Opin Oncol 3:254-271.
45. Storek J, Gooley T, Siadak M, Bensinger WI, Maloney DG, Chauncey TR, et al. (1997). Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 90:4705-4709.
46. Sullivan KM, Shulman HM, Storb R, Weiden PL (1981). Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 57:267-276.